Apple Watch app for monitoring Parkinson’s symptoms earns FDA clearance

MedTech Dive November 21, 2022
Nick Paul Taylor

Dive Brief:

• H2o Therapeutics has received 510(k) clearance for an Apple Watch app that monitors Parkinson’s disease symptoms such as tremors and dyskinesia.
• The smartwatch app uses Apple’s movement disorder API and the inertial sensors of the device to provide insights into patients’ symptoms between visits to their clinicians.
• Apple validated the technology in a clinical trial, positioning h2o to create an app that enables the sharing of objective Parkinson’s symptom data between patients and medical professionals.

Dive Insight:

Apple laid the foundation for the app last year by publishing the results of a clinical trial of 343 people with Parkinson’s disease. The tech company ran the study to evaluate its Motor fluctuations Monitor for Parkinson’s Disease (MM4PD)...

Today's Sponsors

Today's Sponsor